Marco Infante

Marco Infante is an Adjunct Professor of Endocrinology at UniCamillus – Saint Camillus International University of Health Sciences (Rome, Italy) and an Affiliate Associate Professor at the Diabetes Research Institute (DRI) of the University of Miami Miller School of Medicine. His research focuses on type 1 diabetes, immunotherapy, pancreatic islet transplantation, and the role of vitamin D and omega-3 fatty acids in autoimmune diseases. He holds editorial roles in journals like Frontiers in Clinical Diabetes and Healthcare and has authored over 70 peer-reviewed publications. Notable awards include the FACN designation (2021), Sigma Xi membership (2023), and a U.S. Extraordinary Ability O1 Visa (2024).

Education: M.D. (Sapienza University of Rome, 2014), Ph.D. (University of Rome Tor Vergata, 2023), and certifications in Endocrinology (2019) and Clinical Ultrasound (2016/2018). Professional affiliations include the American Diabetes Association, IPITA, and DRIF.

Research interests span diabetes technology, immunomodulation, and nutritional interventions. He has pioneered studies on VIDPP-4i (vitamin D and DPP-4 inhibitors) for autoimmune diabetes and explored novel therapies for insulin resistance and metabolic disorders.

Grants and collaborations include the NIIMA network (Distinguished Supervisor, 2020) and international studies on diabetes complications. His clinical work integrates endocrine ultrasound diagnostics with metabolic disease management.